Clinical Trials Browser

Phase 1/2 × Carcinogenesis × Dermatologic × Clear all

NCT01079741 2018-02-13

Safety Study of Adjuvant Vaccine to Treat Melanoma Patients

Phase 1/2 Completed

34 enrolled 10 charts

Melanoma, Neoplasms, Skin Neoplasms, Carcinogenesis